Rydex Biotechnology Fund Class C (RYCFX) is a Health fund with $109.00 Million in assets. The fund allocates 39.42% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is AbbVie, Inc. at 8.83% of total assets. This is followed by Amgen, Inc. (5.31%) and Gilead Sciences, Inc. (4.89%).